EFLM Strategic Conference 2024

Program

Monday, 23 September 2024

	FIRST SESSION: CREATING VALUE FOR USERS
8.45	Opening Remarks, Mario Plebani Chairs: T. Ozben, T. Zima, M. Plebani
9.00-9.30	The value of laboratory information: navigating between quality and errors M. Plebani (Padova, Italy)
9.30-9.50	Demand management for appropriate test requesting and clinical laboratory stewardship J. Cadamuro (Salzburg, Austria)
9.50-10.10	Transforming laboratory data into clinical information P. Vermeersch (Leuven, Belgium)
10.10-10.30	Process and outcomes measurement S. Jovicic (Belgrade, Serbia)
	Coffee break
11.00-11.20	Sustainable laboratory medicine (Green and smart clinical laboratories) T. Ozben (Antalya, Turkiye)
11.20-11.40	Development of new reimbursement models T. Trenti (Modena, Italy)
11.40-12.00	Patient empowerment B. McMillan (Manchester, UK)
12.00-13.00	Discussion Discussants: A.R. Horvath (Randwick, Australia), M. Panteghini (Milan, Italy)
	SECOND SESSION: CHANGING THE ORGANIZATION Chairs: P. Fernandez-Calle, K.P. Kohse, M. Langlois
14.00-14.30	Integration - overcoming silos in health care C. Lowe (Cambridge, UK)
14.30-14.50	Integrated diagnostics J. Lennerz (Boston, USA)
14.50-15.10	Integrated Diagnostics in Hematological cancers E. Macintyre (Paris, France)
15.10-15.30	Networking, decentralized laboratory testing and Point-of-care (recorded) S. Sandberg (Bergen, Norway)
	Coffee break
16.00-16.20	Home testing, wearables and remote patient monitoring G. Lippi (Verona, Italy)
16.20-16.40	Clinical Diagnostic and therapeutic pathways C. Gabelli (Padova, Italy)
16.40-17.00	Information technology, digitalization and health electronic record A. Padoan (Padova, Italy)
17.00-18.00	Discussion Discussants: F. Ceriotti (Milano, Italy), P. Lankinen (Helsinki, Finland)

Tuesday, 24 September 2024

	THIRD SESSION: ETHICAL ASPECTS IN LABORATORY MEDICINE Chairs: E. Homsak, D. Vitkus, K. Peoc’h
9.00-9.20	Ethical challenges in laboratory medicine (covering big data) G. Banfi (Milano, Italy)
9.20-9.40	Ethics in scientific research and publication J. Wiencek (Vanderbilt, USA)
9.40-10.00	Challenges to the Brain-to-Brain loop I. Lubin (Atlanta, USA)
10.00-10.20	Direct-to-consumer laboratory testing M. Orth (Stuttgart, Germany)
10.20-10.40	The role and ethical aspects of Artificial Intelligence in value-based laboratory medicine A. Carobene (Milano, Italy)
10.40-11.00	Disruptive innovations: between fakes and value for users T. Hankemeier (Leiden, The Netherlands)
11.00-12.00	Discussion Discussants: M. Zaninotto (Padova, Italy), P. Bossuyt (Amsterdam, The Netherlands)
	Coffee break
	FOURTH SESSION: THE FUTURE OF LABORATORY PROFESSIONALS Chairs: M. Ciaccio, D. Pasalic, A.M. Simundic
13.30-13.50	Changing education and training of laboratory medicine professionals T. Zima (Prague, Czech Republic)
13.50-14.10	The new in vitro diagnostic regulation (IVDR) C. Cobbaert (Leiden, The Netherlands)
14.10-14.30	Forecast of the diagnostic market D. Sartiaux (Brussels, Belgium)
14.30-14.50	Biomarkers and personalized medicine R. van Schaik (Rotterdam, The Netherlands)
14.50-15.20	Future duties and responsibility of laboratory professionals: the role of EFLM in sustaining value-based laboratory medicine M. Plebani (Padova, Italy)
15.20-16.30	Discussion Discussants: E. Macintyre (Paris, France); M. Boggetti (Siena, Italy)
	Conclusion remarks and open discussion on the expectations from participants